Standout Papers

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial ... 2013 2026 2017 2021 482
  1. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (2013)
    Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology

Immediate Impact

2 by Nobel laureates 17 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Antisense oligonucleotide therapeutic approach for Timothy syndrome
2024 StandoutNature
10 intermediate papers

Works of Jeffrey Rothstein being referenced

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
2013 Standout

Author Peers

Author Last Decade Papers Cites
Jeffrey Rothstein 385 323 622 9 967
Xiu Shan 327 190 618 11 1.1k
Ashley Christensen 434 259 449 11 1.0k
Francesco Limone 387 240 596 12 849
Jonathan C. Grima 399 121 508 10 882
Matthew J. Crisp 376 268 555 9 1.1k
Ze’ev Melamed 465 292 740 10 985
Ivan T. Shaw 313 217 673 7 1.1k
Pieter J.L.M. Snijders 313 332 258 22 1.1k
Amr Al‐Saif 195 102 514 14 996
Michael L. Coonfield 549 207 558 11 1.1k

All Works

Loading papers...

Rankless by CCL
2026